11 completed. 11 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 11 | Completed 11 |
| Phase 2 | 4 | Completed 4 |
Follow Ulcer: new trials by email Literature Review of Ulcer trials Research Report on Ulcer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nitric Oxide Generating Gel Dressing in Patients With Diabetic Foot Ulcers NOx dressing, Standard of Care - Diabetic Foot Ulcer | Phase 1 / Phase 2 | Completed | Edixomed Ltd | 130 | 2013-06-01 | 2016-01-20 |
| Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one, Test 2= ASA 100 mg and pantoprazole 20 mg capsule formulation two, ASA 100 mg tablet - Ulcers, Duodenal and Gastric | Phase 1 | Completed | GlaxoSmithKline | 24 | 2013-05-16 | 2017-07-13 |
| Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one, Test 2= ASA 100 mg and pantoprazole 20 mg capsule formulation two, ASA 100 mg tablet - Ulcers, Duodenal and Gastric | Phase 1 | Completed | GlaxoSmithKline | 24 | 2013-05-14 | 2017-07-13 |
| The Effect of the Cosmetic Cream NMBM on Leg Ulcers - a Pilot Study NMBM, Compression garments - Ulcer, Venous Ulcer | Phase 1 / Phase 2 | Completed | M.D. Lederman Consulting Ltd | 30 | 2013-02-01 | 2017-01-11 |
| Pharmacokinetics of Diammine Silver Fluoride DIammine SIlver Fluoride - Fluoride and Silver Pharmacokinetics of DSF Applied Topically to Teeth of Adults. Erythema, Bleeding, White Changes, Ulceration and Pigmentation Were Assessed | Phase 1 | Completed | Universidad Peruana Cayetano Heredia | 6 | 2011-07-01 | 2012-08-14 |
| Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination Esomeprazole 40mg/ASA 325mg, Esomeprazole, ASA - Ulcers, Upper GI Symptoms | Phase 1 | Completed | AstraZeneca | 84 | 2008-04-01 | 2009-03-12 |
| FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers FGF-1 - Chronic Wounds, Diabetes | Phase 1 | Completed | Venturis Therapeutics, Inc. | 8 | 2005-09-02 | 2026-08-19 |
| Stem Cell Study for Patients With Leg Ulcer/Gangrene Autologous peripheral blood CD34 positive cell therapy - Leg Pain, Ulcer | Phase 1 / Phase 2 | Completed | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 15 | 2003-11-01 | 2009-02-09 |
| Gene Therapy to Improve Wound Healing in Patients With Diabetes GAM501 - Wounds and Injuries, Diabetes | Phase 1 | Completed | Tissue Repair Company | 21 | 2002-08-01 | 2007-11-20 |
| Morphine Gel for Bedsores Pain relief for pressure ulcers - Decubitus Ulcer | Phase 1 / Phase 2 | Completed | University of Kansas | 75 | 2000-03-01 | 2013-05-20 |
| Safety and Tolerability of the Vaginal Gel PRO 2000/5 PRO 2000 - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 60 | 2008-07-30 |
Diabetes Mellitus (2) · Diabetic Foot (2) · Pain (2) · Varicose Ulcer (2) · Adenoviridae Infections (1) · Agnosia (1) · Bronchiolitis Obliterans Syndrome (1) · Gangrene (1) · HIV Infections (1) · HIV Seropositivity (1) · Hemorrhage (1) · Ischemia (1) · Leg Ulcer (1) · Peripheral Arterial Disease (1)
Pathologic Processes (11) · Pathological Conditions, Signs and Symptoms (11) · Cardiovascular Diseases (5) · Skin Diseases (5) · Skin and Connective Tissue Diseases (5) · Skin Ulcer (4) · Vascular Diseases (4) · Endocrine System Diseases (3) · Leg Ulcer (3) · Diabetes Complications (2) · Diabetic Angiopathies (2) · Diabetic Neuropathies (2) · Foot Ulcer (2) · Glucose Metabolism Disorders (2) · Immune System Diseases (2)
Pantoprazole (2) · Tablets (2) · Tablets, Enteric-Coated (2) · Analgesia (1) · Aspirin (1) · Esomeprazole (1) · Fibroblast Growth Factor 1 (1) · Hydrogen (1) · PRO 2000 (1) · Standard of Care (1)
GlaxoSmithKline (2) · AstraZeneca (1) · Edixomed Ltd (1) · M.D. Lederman Consulting Ltd (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Tissue Repair Company (1) · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan (1) · Universidad Peruana Cayetano Heredia (1) · University of Kansas (1) · Venturis Therapeutics, Inc. (1)
United States (4) · India (2) · Israel (1) · Japan (1) · Peru (1) · United Kingdom (1)
Arthur Tucker, PhD (1) · Barbara Sosnowski, PhD (1) · Christopher Billings ., D.O (1) · Elsa Vasquez, DDS (1) · Jorge Castillo, DDS MSD PhD (1) · Ken Mayer (1) · Peter Milgrom, DDS (1) · Salim Abdool Karim (1) · Shoshana Greenberger, MD PhD (1) · Takayuki Asahara, M.D. (1) · Teresa D. Long, MD (1) · Thomas E Serena, MD (1)
PMID 19711453, PMID 22877866, PMID 23272643
R01AR045506 (1), R44AR046154 (1)